Mark E. Robson, MD
Breast Medical Oncologist & Clinical Geneticist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Breast Cancer
- General Hematology/Oncology
- Genetic Predisposition to Cancer
About Me
- Chief, Breast Medicine Service
I am a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. I concentrate on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, I work to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs.
Along the same lines, my research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types.
Read more
Consistent with the goals I pursue in my clinical genetics work, my oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, I participate in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, I also maintain a separate practice where I coordinate screening for women with mutations in BRCA1 or BRCA2.
A breast medical oncologist is a cancer doctor who specializes in breast cancer.
A clinical geneticist is a scientist with special training in diagnosing and treating genetic conditions. They can help explain your risk of getting a genetic condition that is passed on from parents to children.
My Specialties
- Breast Cancer
- General Hematology/Oncology
- Genetic Predisposition to Cancer
- Cancer Risk Counseling
Education
- MD, University of Virginia
Residencies
- Internal Medicine - Walter Reed Army Medical Center
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2014, 2018-2020)
Fellowships
- Medicine - Walter Reed Army Medical Center
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Robson sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Odessa M. Williams. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.
Clinical Trials
- Clinical Trials Investigated by Dr. Robson
- A Study of Denosumab to Prevent Breast Cancer in Women With an Inherited BRCA1 Mutation
- Clinical Trials Co-Investigated by Dr. Robson
- A Phase 3 Study of Saruparib (AZD5305) Plus Camizestrant in People With Metastatic Breast Cancer
- A Phase II Study of Olaparib and Pembrolizumab in People with Triple-Negative Breast Cancer or Hormone Receptor-Positive HER2-Negative Breast Cancer with Certain Genetic Mutations
- Responses to Testing for Genetic Risk Modifiers Among Women with BRCA1/2 Mutations
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Robson’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Mark E. Robson discloses the following relationships and financial interests:
-
Artios Pharma Limited
Professional Services and Activities (Uncompensated) -
AstraZeneca
Professional Services and Activities (Uncompensated) -
Change Healthcare Inc.
Professional Services and Activities -
Clinical Care Options
Professional Services and Activities -
Foundation Medicine
Professional Services and Activities (Uncompensated)
-
Genome Quebec
Professional Services and Activities -
myMedEd, Inc.
Professional Services and Activities -
Pfizer, Inc.
Professional Services and Activities (Uncompensated) -
WebMD
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].